ArticleFrontiers in immunology2023

The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.

Zihan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.